ArticleFuture oncology (London, England)2024
Cost of early progression: patients with epidermal growth factor receptor mutated metastatic non-small-cell lung cancer.
Nicole Princic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.